Gensight Biologics SA (SIGHT) — Strategic Asset Allocation Index
Gensight Biologics SA (SIGHT) has a Strategic Asset Allocation Index of 83.4% as of June 2022. Strategic assets (PP&E of €2.67 Million plus long-term investments of €-) total €2.67 Million, measured against net assets of €3.20 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Gensight Biologics SA Strategic Asset Allocation Index (2013–2021)
This chart shows how Gensight Biologics SA's Strategic Asset Allocation Index has evolved across 9 annual periods from 2013 to 2021. As of June 2022, the index stands at 83.4%, representing strategic assets of €2.67 Million against net assets of €3.20 Million EUR. Explore SIGHT operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Gensight Biologics SA (2013–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Gensight Biologics SA from 2013 to 2021, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Gensight Biologics SA (SIGHT) total market value.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 15.9% | €2.55 Million | €2.55 Million | €- | €15.99 Million | ▼ -11.1 pp |
| 2020 | 27.0% | €3.15 Million | €3.15 Million | €- | €11.67 Million | ▼ -9.0 pp |
| 2019 | 36.0% | €4.23 Million | €4.23 Million | €- | €11.75 Million | ▲ +30.1 pp |
| 2018 | 5.8% | €1.40 Million | €1.40 Million | €- | €23.87 Million | ▲ +4.2 pp |
| 2017 | 1.6% | €889.00K | €889.00K | €- | €55.00 Million | ▲ +0.0 pp |
| 2016 | 1.6% | €858.00K | €858.00K | €- | €53.34 Million | ▼ -1.3 pp |
| 2015 | 2.9% | €860.96K | €860.96K | €- | €29.33 Million | ▲ +0.3 pp |
| 2014 | 2.6% | €278.00K | €278.00K | €- | €10.58 Million | ▲ +0.7 pp |
| 2013 | 1.9% | €325.00K | €325.00K | €- | €16.97 Million | — |